Advertisement

Dermatologic Diseases of the Breast and Nipple

  • Anca Chiriac
Chapter

Abstract

Breast and nipple skin disorders cover a large spectrum of cutaneous lesions, beyond common benign and malignant tumors of the breast. Recognizing dermatologic diseases of the breast and nipple could aid in improved diagnosis and treatment.

Keywords

Dermatitis Nipple eczema Psoriasis Vitiligo Hyperkeratosis Folliculitis 

References

  1. 1.
    Whitaker-Worth DL, Carlone V, Susser WS, Phelan N, Grant-Kels JM. Dermatologic diseases of the breast and nipple. J Am Acad Dermatol. 2000;43:733–51. quiz 752–4CrossRefPubMedGoogle Scholar
  2. 2.
    Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovenerol. 1980;60:44–7.Google Scholar
  3. 3.
    Kim SK, Won YH, Kim SJ. Nipple eczema: a diagnostic challenge of allergic contact dermatitis. Ann Dermatol. 2014;26:413–4.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Herro EM, Friedlander SF, Jacob SE. Bra-associated allergic contact dermatitis: p-tert-butylphenol formaldehyde resin as the culprit. Pediatr Dermatol. 2012;29:540–1.CrossRefPubMedGoogle Scholar
  5. 5.
    Garcia M, del Pozo MD, Díez J, Muñoz D, de Corrès LF. Allergic contact dermatitis from a beeswax nipple-protective. Contact Dermatitis. 1995;33:440–1.CrossRefPubMedGoogle Scholar
  6. 6.
    Boniface K, Taïeb A, Seneschal J. New insights into immune mechanisms of vitiligo. G Ital Dermatol Venereol. 2016;151:44–54.PubMedGoogle Scholar
  7. 7.
    Levy-Franckel A. Les hyperkeratoses de l’areole et du mamelon. Paris Med. 1938;28:63–6.Google Scholar
  8. 8.
    Ortonne J, el Baze P, Juhlin L. Nevoid hyperkeratosis of the nipple and areola mammae: ineffectiveness of etretinate therapy. Acta Derm Venereol. 1986;66:175–7.PubMedGoogle Scholar
  9. 9.
    Mehregan AH, Rahbari H. Hyperkeratosis of the nipple and areola. Arch Dermatol. 1977;113:1691–2.CrossRefPubMedGoogle Scholar
  10. 10.
    Rodallec J, Moral P, Guilaine G, Civatte J. Hyperkeratose de l’areole mammaire unilateral recidivante chez une femme enceinte. Ann Dermatol Venereol. 1978;105:527–8.PubMedGoogle Scholar
  11. 11.
    Schwartz RA. Hyperkeratosis of the nipple and areola. Arch Dermatol. 1978;114:1844–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Mehanna A, Malak JA, Kibbi AG. Hyperkeratosis of the nipple and areola: report of 3 cases. Arch Dermatol. 2001;137:1327–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Li C, Ran Y, Sugita T, Zhang E, Xie Z, Cao L. Malassezia associated hyperkeratosis of the nipple in young females: report of three cases. Indian J Dermatol Venereol Leprol. 2014;80:78–80.CrossRefPubMedGoogle Scholar
  14. 14.
    Parimalam K, Chandrakala C, Ananthi M, Karpagam B. Nipple hyperkeratosis due to malassezia furfur showing excellent response to itraconazole. Indian J Dermatol. 2015;60:324.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Vanneste L, Wolter P, Van den Oord JJ, Stas M, Garmyn M. Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients. J Eur Acad Dermatol Venereol. 2015;29:61–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Tanguay KE, McBean MR, Jain E. Nipple candidiasis among breastfeeding mothers. Case-control study of predisposing factors. Can Fam Physician. 1994;40:1407–13.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61:303–18.CrossRefPubMedGoogle Scholar
  18. 18.
    Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation and pathogenesis. J Am Acad Dermatol. 2011;64:217–28.CrossRefPubMedGoogle Scholar
  19. 19.
    Ballester I, Bañuls J, Pérez-Crespo M, Lucas A. Extragenital bullous lichen sclerosus atrophicus. Dermatol Online J. 2009;15:6.PubMedGoogle Scholar
  20. 20.
    Koblenzer CS. Dermatitis artefacta: clinical features and approaches to treatment. Am J Clin Dermatol. 2000;1:47–55.CrossRefPubMedGoogle Scholar
  21. 21.
    Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461–73.CrossRefPubMedGoogle Scholar
  22. 22.
    Sood SK, Salzman MB, Johnson BJ, Happ CM, Feig K, Carmody L, et al. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis. 1997;175:996–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann N Y Acad Sci. 1988;539:4–15.CrossRefPubMedGoogle Scholar
  24. 24.
    Lipsker D. Dermatological aspects of Lyme borreliosis. Med Mal Infect. 2007;37:540–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Colli C, Leinweber B, Müllegger R, Chott A, Kerl H, Cerroni L. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol. 2004;31:232–40.CrossRefPubMedGoogle Scholar
  26. 26.
    Lee BB, Laredo J. Hemangioma and venous/vascular malformations are different as an apple and an orange! Acta Phlebol. 2012;13:1–3.Google Scholar
  27. 27.
    Francès C, Barète S, Piette JC. Manifestations dermatologiques du lupus. Rev Med Interne. 2008;29:701–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Anca Chiriac
    • 1
    • 2
    • 3
  1. 1.Department of DermatologyNicolina Medical CenterIaşiRomania
  2. 2.Department of Dermato-PhysiologyApollonia UniversityIaşiRomania
  3. 3.P. Poni Institute of Macromolecular ChemistryIaşiRomania

Personalised recommendations